Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2021

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential

Leonard Daly
Marius Walter
Charles Craik
Patrick Eyers
Yann Gambin
Emma Sierecki
Eric Verdin
Edward Emmott
  • Fonction : Auteur correspondant
  • PersonId : 1141833

Connectez-vous pour contacter l'auteur

Résumé

Abstract SARS-CoV-2 is the causative agent behind the COVID-19 pandemic, responsible for over 170 million infections, and over 3.7 million deaths worldwide. Efforts to test, treat and vaccinate against this pathogen all benefit from an improved understanding of the basic biology of SARS-CoV-2. Both viral and cellular proteases play a crucial role in SARS-CoV-2 replication. Here, we study proteolytic cleavage of viral and cellular proteins in two cell line models of SARS-CoV-2 replication using mass spectrometry to identify protein neo-N-termini generated through protease activity. We identify previously unknown cleavage sites in multiple viral proteins, including major antigens S and N: the main targets for vaccine and antibody testing efforts. We discover significant increases in cellular cleavage events consistent with cleavage by SARS-CoV-2 main protease, and identify 14 potential high-confidence substrates of the main and papain-like proteases. We show that siRNA depletion of these cellular proteins inhibits SARS-CoV-2 replication, and that drugs targeting two of these proteins: the tyrosine kinase SRC and Ser/Thr kinase MYLK, show a dose-dependent reduction in SARS-CoV-2 titres. Overall, our study provides a powerful resource to understand proteolysis in the context of viral infection, and to inform the development of targeted strategies to inhibit SARS-CoV-2 and treat COVID-19.

Domaines

Virologie
Fichier principal
Vignette du fichier
s41467-021-25796-w.pdf (10.85 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

pasteur-03654295 , version 1 (28-04-2022)

Licence

Paternité

Identifiants

Citer

Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, Philip Brownridge, Dominic Bryne, et al.. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential. Nature Communications, 2021, 12 (1), pp.5553. ⟨10.1038/s41467-021-25796-w⟩. ⟨pasteur-03654295⟩
7 Consultations
57 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More